Xencor (XNCR) Change in Acquisitions & Divestments (2015 - 2026)

Xencor (XNCR) reported Change in Acquisitions & Divestments of $100.0 million for Q1 2026, down 15.98% year-over-year from $119.0 million in Q1 2025, and up 331.58% quarter-over-quarter from $23.2 million in Q4 2025.

Xencor (XNCR) Change in Acquisitions & Divestments (2015 - 2026) Analysis & Trends

Xencor (XNCR) has 12 years of Change in Acquisitions & Divestments data on file, last reported at $100.0 million in Q1 2026.

  • Change in Acquisitions & Divestments for Q1 2026 came in at $100.0 million, down 15.98% year-over-year; the trailing twelve-month figure through Mar 2026 was $17.9 million (down 84.5% YoY), and the FY2025 annual result was $36.9 million, up 456.34% from the prior year.
  • Change in Acquisitions & Divestments improved to $100.0 million in Q1 2026 per XNCR's latest filing, from $23.2 million in the prior quarter.
  • Over five years, Change in Acquisitions & Divestments peaked at $556.1 million in Q3 2023 and troughed at -$556.1 million in Q4 2023.
  • A 5-year average of $8.4 million and a median of $23.2 million in 2025 frame the typical range for Change in Acquisitions & Divestments.
  • The sharpest annual moves came in 2023 and 2025: Change in Acquisitions & Divestments sank 374.09% in 2023, then surged 1093.55% in 2025.
  • A 5-year view of Change in Acquisitions & Divestments shows it stood at -$205.3 million in 2022, then plunged by 170.88% to -$556.1 million in 2023, then advanced by 15.61% to -$469.3 million in 2024, then jumped by 104.94% to $23.2 million in 2025, then jumped by 331.58% to $100.0 million in 2026.
  • Business Quant data shows XNCR's Change in Acquisitions & Divestments at $100.0 million in Q1 2026, $23.2 million in Q4 2025, and $379000.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn -
7 Psyence Biomedical 212.16 Bn 212.16 Bn -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn
9 Abivax 91.96 Bn 91.96 Bn -
10 Xencor 953.38 Mn 878.64 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2026 99.97 Mn
Mar 31, 2026 99.97 Mn
Dec 31, 2025 23.16 Mn
Dec 31, 2025 23.16 Mn
Sep 30, 2025 379,000.00
Sep 30, 2025 379,000.00
Jun 30, 2025 -105.59 Mn
Jun 30, 2025 -105.59 Mn
Mar 31, 2025 118.99 Mn
Mar 31, 2025 118.99 Mn
Dec 31, 2024 -469.27 Mn
Dec 31, 2024 -469.27 Mn
Sep 30, 2024 117.98 Mn
Sep 30, 2024 117.98 Mn
Jun 30, 2024 347.97 Mn
Jun 30, 2024 347.97 Mn
Mar 31, 2024 9.97 Mn
Mar 31, 2024 9.97 Mn
Dec 31, 2023 -556.09 Mn
Dec 31, 2023 -556.09 Mn